Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Tonix Pharmaceuticals Appoints Thomas Englese As Chief Commercial Officer

PUBLIC · TNXPSep 08, 2026•about 2 hours ago

Position

Chief Commercial Officer

Company

Tonix Pharmaceuticals Holding Corp

Thomas Englese
Chatham

Description

On September 8, 2026, Tonix Pharmaceuticals announced the appointment of Thomas Englese as the Company’s Chief Commercial Officer, effective immediately. This strategic hire aims to strengthen the commercial leadership of the company. Englese brings valuable experience to the role.

Company Information

Company

Tonix Pharmaceuticals Holding Corp

Location

Chatham, Georgia, United States

About

Tonix Pharmaceuticals is a biopharmaceutical company based in Berkeley Heights, New Jersey, with additional offices in Chatham, New Jersey. Founded in 2007 and led by President and CEO Seth H. Lederman, M.D., Tonix focuses on developing and commercializing therapies for central nervous system disorders, immunology, infectious diseases, and rare diseases. The company is publicly traded on the NASDAQ under the ticker TNXP. Tonix has a strong commercial infrastructure supporting its FDA-approved products, including TONMYA™, the first new prescription drug for fibromyalgia approved in over 15 years, and treatments for acute migraines such as Zembrace® SymTouch® and Tosymra®. The company also offers clinical trial services and maintains a robust pipeline of products targeting various conditions, including vaccines for smallpox, monkeypox, and COVID-19. Tonix serves patients with specific medical needs, including those suffering from fibromyalgia, migraines, PTSD, autoimmune disorders, and rare diseases.

Don't miss Tonix Pharmaceuticals Holding Corp's next move

Get an email the moment Tonix Pharmaceuticals Holding Corp changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Tonix Pharmaceuticals Holding Corp's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Tonix Pharmaceuticals Holding Corp changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.